Chemical Carcinogenesis
暂无分享,去创建一个
[1] S. Cohen,et al. Cell Proliferation and Carcinogenesis , 2008 .
[2] C. J. Reed,et al. Lack of formic acid production in rat hepatocytes and human renal proximal tubule cells exposed to chloral hydrate or trichloroacetic acid. , 2007, Toxicology.
[3] V Emuss,et al. The Molecular Biology of Cancer , 2006, British Journal of Cancer.
[4] Eugene V Koonin,et al. Signs of positive selection of somatic mutations in human cancers detected by EST sequence analysis , 2006, BMC Cancer.
[5] Steven M. Lipkin,et al. Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis , 2006, Nucleic acids research.
[6] D. Kennedy,et al. DNA adducts, DNA repair genotype/phenotype and cancer risk. , 2005, Mutation research.
[7] H. Tazawa,et al. Prevention of human cancer by modulation of chronic inflammatory processes. , 2005, Mutation research.
[8] Z R Li,et al. Prediction of genotoxicity of chemical compounds by statistical learning methods. , 2005, Chemical research in toxicology.
[9] Mihi Yang,et al. Molecular Epidemiology of Lung Cancer in Female Passive Smokers , 2005, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[10] M. Blagosklonny,et al. Molecular theory of cancer , 2005, Cancer biology & therapy.
[11] Andreas Luch,et al. Nature and nurture – lessons from chemical carcinogenesis , 2005, Nature Reviews Cancer.
[12] K. Dixon,et al. Genetic alterations and DNA repair in human carcinogenesis. , 2004, Seminars in cancer biology.
[13] Audrey Player,et al. Laser capture microdissection, microarrays and the precise definition of a cancer cell , 2004, Expert review of molecular diagnostics.
[14] Y. Oda. Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system. , 2004, Mutation research.
[15] L. Hudson,et al. Oxidative stress and apoptosis in metal ion-induced carcinogenesis. , 2004, Free radical biology & medicine.
[16] Ricky A. Sharma,et al. Biological Relevance of Adduct Detection to the Chemoprevention of Cancer , 2004, Clinical Cancer Research.
[17] Jan G Hengstler,et al. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. , 2004, Toxicology letters.
[18] K. Golka,et al. Carcinogenicity of azo colorants: influence of solubility and bioavailability. , 2004, Toxicology letters.
[19] X. Chen,et al. The common and distinct target genes of the p53 family transcription factors , 2004, Cellular and Molecular Life Sciences CMLS.
[20] B. Mahadevan,et al. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention. , 2004, Mutation research.
[21] M. Bondy. Estimated risk in malignancy: the emerging field of molecular epidemiology. , 2004, Clinical advances in hematology & oncology : H&O.
[22] P. Hanawalt,et al. Functional characterization of global genomic DNA repair and its implications for cancer. , 2003, Mutation research.
[23] Tomohiro Sawa,et al. Chemical basis of inflammation-induced carcinogenesis. , 2003, Archives of biochemistry and biophysics.
[24] A. Dennison,et al. Chemoprevention of gastrointestinal malignancies , 2003, ANZ journal of surgery.
[25] Yuanyuan Wang,et al. Predictive Toxicology: Benchmarking Molecular Descriptors and Statistical Methods , 2003, J. Chem. Inf. Comput. Sci..
[26] C. Kemp,et al. p27 Kip1 (Cdkn1b)-Deficient Mice Are Susceptible to Chemical Carcinogenesis and May Be a Useful Model for Carcinogen Screening , 2003, Toxicologic pathology.
[27] Yan Yan,et al. Molecular mechanisms of nickel carcinogenesis: gene silencing by nickel delivery to the nucleus and gene activation/inactivation by nickel-induced cell signaling. , 2003, Journal of environmental monitoring : JEM.
[28] J. Trosko. The role of stem cells and gap junctional intercellular communication in carcinogenesis. , 2003, Journal of biochemistry and molecular biology.
[29] E. Friedberg,et al. DNA damage and repair , 2003, Nature.
[30] M. Dewhirst,et al. Carcinogenic effects of hyperthermia , 2003, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[31] M. Webber,et al. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. , 2002, Journal of the National Cancer Institute.
[32] J. Haseman,et al. The role of transgenic mouse models in carcinogen identification. , 2002, Environmental health perspectives.
[33] A. Hartwig,et al. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. , 2002, Environmental health perspectives.
[34] J. Ford,et al. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] W. Waddell. Thresholds of carcinogenicity of flavors. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[36] Thomas Tan,et al. p53 Binds and Activates the Xeroderma Pigmentosum DDB2 Gene in Humans but Not Mice , 2002, Molecular and Cellular Biology.
[37] W. Lutz. Differences in individual susceptibility to toxic effects of chemicals determine the dose-response relationship and consequences of setting exposure standards. , 2002, Toxicology letters.
[38] S. Weitzman,et al. Chronic inflammation and cancer. , 2002, Oncology.
[39] B. Tóth. Species susceptibilities to chemical carcinogenes: a critical appraisal of the roles of genetic and viral agents. , 2001, In vivo.
[40] I. V. van Leeuwen,et al. From exposure to effect: a comparison of modeling approaches to chemical carcinogenesis. , 2001, Mutation research.
[41] W. Lutz,et al. Susceptibility differences in chemical carcinogenesis linearize the dose-response relationship: threshold doses can be defined only for individuals. , 2001, Mutation research.
[42] G. Williams,et al. Mechanisms of chemical carcinogenesis and application to human cancer risk assessment. , 2001, Toxicology.
[43] J. Jeng,et al. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. , 2001, Oral oncology.
[44] L Tomatis,et al. Carcinogenesis bioassays: study duration and biological relevance. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[45] F. Guengerich. Forging the links between metabolism and carcinogenesis. , 2001, Mutation research.
[46] F. Gonzalez,et al. Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice. , 2001, Mutation research.
[47] K. Tanaka,et al. Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies. , 2001, Mutation research.
[48] M. Detmar,et al. Thrombospondin‐2 plays a protective role in multistep carcinogenesis: a novel host anti‐tumor defense mechanism , 2001, The EMBO journal.
[49] J. French,et al. New models for assessing carcinogenesis: an ongoing process. , 2001, Toxicology letters.
[50] F. Gonzalez,et al. The use of gene knockout mice to unravel the mechanisms of toxicity and chemical carcinogenesis. , 2001, Toxicology letters.
[51] M Ingelman-Sundberg,et al. Genetic variability in susceptibility and response to toxicants. , 2001, Toxicology letters.
[52] J. Trosko,et al. Commentary: Is the concept of “tumor promotion” a useful paradigm? , 2001, Molecular carcinogenesis.
[53] J. Frowein. Hypothesis: chemical carcinogenesis mediated by a transiently active carcinogen receptor , 2001, Cytogenetic and Genome Research.
[54] H. Müller-Hermelink,et al. p53 and c-Jun Functionally Synergize in the Regulation of the DNA Repair Gene hMSH2 in Response to UV* , 2000, The Journal of Biological Chemistry.
[55] John R. W. Masters,et al. Human cancer cell lines: fact and fantasy , 2000, Nature Reviews Molecular Cell Biology.
[56] R. Kolodner,et al. Proliferating cell nuclear antigen and Msh2p-Msh6p interact to form an active mispair recognition complex , 2000, Nature Genetics.
[57] Anastassis Perrakis,et al. The crystal structure of DNA mismatch repair protein MutS binding to a G·T mismatch , 2000, Nature.
[58] J. Klaunig,et al. Epigenetic mechanisms of chemical carcinogenesis , 2000, Human & experimental toxicology.
[59] W. Lutz,et al. A true threshold dose in chemical carcinogenesis cannot be defined for a population, irrespective of the mode of action , 2000, Human & experimental toxicology.
[60] K. Vousden,et al. A ribonucleotide reductase gene is a transcriptional target of p53 and p73 , 2000, Oncogene.
[61] Q. Khan,et al. Diverse chemical carcinogens fail to induce G(1) arrest in MCF-7 cells. , 2000, Carcinogenesis.
[62] F. Oesch,et al. Metabolic Detoxification: Implications for Thresholds , 2000, Toxicologic pathology.
[63] F. Guengerich. Metabolism of chemical carcinogens. , 2000, Carcinogenesis.
[64] R. Santella,et al. Carcinogen macromolecular adducts and their measurement. , 2000, Carcinogenesis.
[65] A. Balmain,et al. Carcinogenesis in mouse and human cells: parallels and paradoxes. , 2000, Carcinogenesis.
[66] K. Vousden,et al. Lack of p53-Mediated G1 Arrest in Response to an Environmental Carcinogen , 1999, Oncology.
[67] J. Weisburger. Carcinogenicity and mutagenicity testing, then and now. , 1999, Mutation research.
[68] P. Vasseur,et al. Epigenetic events during the process of cell transformation induced by carcinogens (review). , 1999, Oncology reports.
[69] W. Lutz,et al. Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. , 1999, Mutation research.
[70] T. Myers,et al. Gadd45, a p53-Responsive Stress Protein, Modifies DNA Accessibility on Damaged Chromatin , 1999, Molecular and Cellular Biology.
[71] U. Vogel,et al. Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients. , 1999, Mutation research.
[72] P. Hanawalt,et al. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[73] G. Morris,et al. p53-Mediated Regulation of Proliferating Cell Nuclear Antigen Expression in Cells Exposed to Ionizing Radiation , 1999, Molecular and Cellular Biology.
[74] W. Lutz,et al. Dose-response relationships in chemical carcinogenesis: superposition of different mechanisms of action, resulting in linear-nonlinear curves, practical thresholds, J-shapes. , 1998, Mutation research.
[75] T. Wang,et al. Genetic toxicity of N-methylcarbamate insecticides and their N-nitroso derivatives. , 1998, Mutagenesis.
[76] J. Weisburger,et al. Worldwide prevention of cancer and other chronic diseases based on knowledge of mechanisms. , 1998, Mutation research.
[77] R C Garner,et al. The role of DNA adducts in chemical carcinogenesis. , 1998, Mutation research.
[78] R. Tennant. Evaluation and validation issues in the development of transgenic mouse carcinogenicity bioassays. , 1998, Environmental health perspectives.
[79] T. Shirai,et al. Studies of initiation and promotion of carcinogenesis by N-nitroso compounds. , 1998, Cancer letters.
[80] R R Maronpot,et al. A Symposium Summary and Perspective on Comparative Molecular Biology of Cancer , 1996, Toxicologic pathology.
[81] R. Maronpot,et al. The Contribution of the Mouse in Hazard Identification Studies , 1996, Toxicologic pathology.
[82] J Ashby,et al. Prediction of rodent carcinogenicity for 30 chemicals. , 1996, Environmental health perspectives.
[83] H. Bartsch,et al. The role of individual susceptibility in cancer burden related to environmental exposure. , 1996, Environmental health perspectives.
[84] R. Melnick,et al. Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis. , 1996, Environmental health perspectives.
[85] R. Tennant,et al. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. , 1995, Environmental health perspectives.
[86] S. Cohen,et al. Role of urinary physiology and chemistry in bladder carcinogenesis. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[87] N. Gorelick,et al. Genotoxicity in the rodent urinary bladder. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[88] R. Mehta. The potential for the use of cell proliferation and oncogene expression as intermediate markers during liver carcinogenesis. , 1995, Cancer letters.
[89] S. Cohen,et al. Rodent bladder tumors do not always predict for humans. , 1995, Cancer letters.
[90] T. Vartiainen,et al. Drinking water mutagenicity and gastrointestinal and urinary tract cancers: an ecological study in Finland. , 1994, American journal of public health.
[91] P. Farmer,et al. Carcinogen adducts: use in diagnosis and risk assessment. , 1994, Clinical chemistry.
[92] J. Huff,et al. Cell proliferation and chemical carcinogenesis: symposium overview. , 1993, Environmental health perspectives.
[93] J. Barrett,et al. Mechanisms of multistep carcinogenesis and carcinogen risk assessment. , 1993, Environmental health perspectives.
[94] H. Bartsch,et al. Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver. , 1992, Carcinogenesis.
[95] L. Ellwein,et al. Genetic errors, cell proliferation, and carcinogenesis. , 1991, Cancer research.
[96] I. Weinstein. Cancer prevention: recent progress and future opportunities. , 1991, Cancer research.
[97] Y. Dragan,et al. Facts and theories concerning the mechanisms of carcinogenesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[98] L. Ellwein,et al. Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[99] I. Weinstein. Strategies for inhibiting multistage carcinogenesis based on signal transduction pathways. , 1988, Mutation research.
[100] H J Clewell,et al. Pharmacokinetics, biochemical mechanism and mutation accumulation: a comprehensive model of chemical carcinogenesis. , 1988, Toxicology letters.
[101] J. Barrett,et al. Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment. , 1987, Environmental health perspectives.
[102] D. Gaylor,et al. Relative potency of chemical carcinogens in rodents. , 1986, Risk analysis : an official publication of the Society for Risk Analysis.
[103] C. Wild,et al. Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. , 1986, Carcinogenesis.
[104] G H Loew,et al. Computer-assisted mechanistic structure-activity studies: application to diverse classes of chemical carcinogens. , 1985, Environmental health perspectives.
[105] E. Farber. The multistep nature of cancer development. , 1984, Cancer research.
[106] R. Scott,et al. Mechanisms for the initiation and promotion of carcinogenesis: a review and a new concept. , 1984, Mayo Clinic proceedings.
[107] R. Peto,et al. Initiation and promotion at different ages and doses in 2200 mice. III. Linear extrapolation from high doses may underestimate low-dose tumour risks. , 1981, British Journal of Cancer.
[108] R. Peto,et al. Initiation and promotion at different ages and doses in 2200 mice. I. Methods, and the apparent persistence of initiated cells. , 1981, British Journal of Cancer.
[109] S. Neidle. Carcinogen binding to DNA , 1978, Nature.
[110] V. Potter. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert Lecture. , 1978, British Journal of Cancer.
[111] K Yamagiwa,et al. Experimental study of the pathogenesis of carcinoma , 1977, CA: a cancer journal for clinicians.
[112] A. Sarasin,et al. How chemicals may induce cancer. , 1976, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[113] D. Schmähl. Combination effects in chemical carcinogenesis (experimental results). , 1976, Oncology.
[114] J. Miller,et al. Metabolic activation and reactivity of chemical carcinogens. , 1975, Mutation research.
[115] F. Sobels. Charlotte Auerbach and chemical mutagenesis. , 1975, Mutation research.
[116] N. Niles. Pathologic Basis of Disease , 1974 .
[117] L. Foulds. The experimental study of tumor progression: a review. , 1954, Cancer research.
[118] J. Miller,et al. In vivo combinations between carcinogens and tissue constituents and their possible role in carcinogenesis. , 1952, Cancer research.
[119] I. Berenblum,et al. The Role of Croton Oil Applications, Associated with a Single Painting of a Carcinogen, in Tumour Induction of the Mouse's Skin , 1947, British Journal of Cancer.
[120] Munir Pirmohamed,et al. The role of metabolic activation in drug-induced hepatotoxicity. , 2005, Annual review of pharmacology and toxicology.
[121] N. Şatıroğlu-Tufan,et al. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents. , 2005, Current cancer drug targets.
[122] C. Bortner,et al. Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway. , 2002, Carcinogenesis.
[123] H. Pitot. Animal models of neoplastic development. , 2001, Developments in biologicals.
[124] José Bello Gutiérrez,et al. Fundamentos de ciencia toxicológica , 2001 .
[125] Z. Ronai,et al. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review. , 2000, Cancer detection and prevention.
[126] P. O'Brien,et al. Cancer Chemoprevention and Apoptosis Mechanisms Induced by Dietary Polyphenolics , 2000, Drug metabolism and drug interactions.
[127] A Kopp-Schneider,et al. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. , 2000, Carcinogenesis.
[128] R. Tennant,et al. Genetically altered mouse models for identifying carcinogens. , 1999, IARC scientific publications.
[129] R. Fanelli,et al. Carcinogen-DNA adducts as tools in risk assessment. , 1999, Advances in experimental medicine and biology.
[130] E. Dybing,et al. Species differences in chemical carcinogenesis of the thyroid gland, kidney and urinary bladder. , 1999, IARC scientific publications.
[131] D. Salvadori,et al. The detection of chemical carcinogens in an alternative medium-term bioassay , 1999 .
[132] J. Huff. Chemicals associated with tumours of the kidney, urinary bladder and thyroid gland in laboratory rodents from 2000 US National Toxicology Program/National Cancer Institute bioassays for carcinogenicity. , 1999, IARC scientific publications.
[133] L. Loeb,et al. Cancer cells exhibit a mutator phenotype. , 1998, Advances in cancer research.
[134] L. Pluta,et al. Long‐term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice , 1998, Environmental and molecular mutagenesis.
[135] E. Moustacchi. [Molecular mechanisms of carcinogenesis: the role of systems of DNA repair]. , 1998, Bulletin de l'Academie nationale de medecine.
[136] F. Oesch,et al. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[137] F. Paumgartten,et al. [Environmental risk factors for gastric cancer: the toxicologist's standpoint] , 1997 .
[138] K. Kinzler,et al. Cancer-susceptibility genes. Gatekeepers and caretakers. , 1997, Nature.
[139] J. Simons. Genetic, epigenetic, dysgenetic, and non-genetic mechanisms in tumorigenesis. , 1995, Critical reviews in oncogenesis.
[140] R. Hayes. Genetic susceptibility and occupational cancer. , 1995, La Medicina del lavoro.
[141] J. C. Barrett,et al. Molecular mechanisms of carcinogenesis in humans and rodents. , 1993, Molecular carcinogenesis.
[142] P. K. Vogt. Cancer genes. , 1993, Western Journal of Medicine.
[143] L B Ellwein,et al. Cancer enhancement by cell proliferation. , 1992, Progress in clinical and biological research.
[144] R B Conolly,et al. Chemically induced cell proliferation in carcinogenesis. , 1992, IARC scientific publications.
[145] N Ito,et al. Medium-term bioassays for carcinogens. , 1992, IARC scientific publications.
[146] S. Cohen. Analysis of modifying factors in chemical carcinogenesis. , 1991, Progress in experimental tumor research.
[147] J. Bakke,et al. The role of cell proliferation in chemical carcinogenesis. , 1990, Progress in clinical and biological research.
[148] S. Yuspa,et al. Chemical carcinogenesis: from animal models to molecular models in one decade. , 1988, Advances in cancer research.
[149] J. Swenberg,et al. Biochemical and morphologic studies of heterogeneous lobe responses in hepatocarcinogenesis. , 1986, Carcinogenesis.
[150] H. Schut,et al. Metabolism of carcinogenic amino derivatives in various species and DNA alkylation by their metabolites. , 1984, Drug metabolism reviews.
[151] D. Kaufman,et al. The Cell Cycle and Chemical Carcinogenesis , 1983 .
[152] M. Kulesz-Martin,et al. Organ specificity and tumor promotion. , 1983, Basic life sciences.
[153] T. Nash. Chemical Carcinogenesis , 1957, Nature.